CUSIP 26818M108COMDYNQ4 2025
62 filings · latest Mar 6, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Janus Henderson Group PLC | 13.89M | $271.60M |
| 2 | Vanguard Group Inc | 11.22M | $219.38M |
| 3 | Blackrock, Inc. | 11.19M | $218.89M |
| 4 | Atlas Venture Life Science Advisors, LLC | 9.13M | $178.59M |
| 5 | State Street Corp | 6.69M | $130.91M |
| 6 | Fmr LLC | 6.57M | $128.51M |
| 7 | Fcpm III Services B.V. | 5.46M | $106.85M |
| 8 | Adage Capital Partners Gp, L.L.C. | 5.17M | $101.16M |
| 9 |
| 4 | Nov 14, 2025 | Janus Henderson Group PLC | 13G/A | 10.4% | 14.75M | SEC |
| 5 | Nov 14, 2025 | Ra Capital Management, L.P. | 13G/A | — | 913.30M | SEC |
| 6 | Nov 13, 2025 | Atlas Venture Fund Xi, L.P. | 13G/A | 4.0% | 5.71M | SEC |
| 7 | Aug 7, 2025 | Janus Henderson Group PLC | 13G/A | 10.1% | 14.39M | SEC |
| 8 | May 15, 2025 | Ra Capital Management, L.P. | 13G/A | 8.5% | 9.71M | SEC |
| 9 | May 15, 2025 | Fordyne B.V. | 13G/A | 4.8% | 5.40M | SEC |
| 10 | May 15, 2025 | Rtw Investments, LP | 13G/A | 1.5% | 1.69M | SEC |
See the full Schedule 13D/13G history for Dyne Therapeutics Inc.
Unlock full history| Orbis Allan Gray Ltd |
| 4.80M |
| $93.93M |
| 10 | Tcg Crossover Management, LLC | 4.62M | $90.27M |